Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients

Nephrology

Volumn 20, Issue 11, 2015, Pages 862-867

  Nongnuch, Arkom ^a,b   Davenport, Andrew ^b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

advanced glycosylation end product (AGE); haemodialysis; mortality; skin autofluorescence (SAF)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTICLE; AUTOFLUORESCENCE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH FLUX HAEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MORTALITY; OUTPATIENT CARE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SKIN AUTOFLUORESCENCE; SMOKING; SURVIVAL; TREATMENT DURATION; URINE VOLUME; ADVERSE EFFECTS; ARTERIOVENOUS SHUNT; KAPLAN MEIER METHOD; METABOLISM; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SKIN; SPECTROFLUOROMETRY; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SKIN; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84943258586     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12519     Document Type: Article

References (33)

1. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58: 353-362.
2. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006; 70: 351-357.
3. Nakashima A, Carrero JJ, Qureshi AR, et al. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2010; 5: 2213-2219.
4. Monnier VM, Cerami A,. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science 1981; 211: 491-493.
5. Meerwaldt R, Hartog JW, Graaff R, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J. Am. Soc. Nephrol. 2005; 16: 3687-3693.
6. Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ,. Profound mishandling of protein glycation degradation products in uremia and dialysis. J. Am. Soc. Nephrol. 2005; 16: 1471-1485.
7. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47: 1324-1330.
8. Ueno H, Koyama H, Fukumoto S, et al. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease. Metabolism 2011; 60: 453-459.
9. Jiang J, Chen P, Chen J, et al. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis. Atherosclerosis 2012; 224: 187-194.
10. Henle T, Deppisch R, Beck W, Hergesell O, Hansch GM, Ritz E,. Advanced glycated end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol. Dial. Transplant. 1999; 14: 1968-1975.
11. Glorieux G, Vanholder R,. New uremic toxins-Which solutes should be removed? Contrib. Nephrol. 2011; 168: 117-128.
12. Gerrits EG, Lutgers HL, Smeets GH, et al. Skin autofluorescence: A pronounced marker of mortality in hemodialysis patients. Nephron Extra 2012; 2: 184-191.
13. Davenport A,. How can dialyzer designs improve solute clearances for hemodialysis patients? Hemodial. Int. 2014; 18 (Suppl 1): S43-47.
14. Davenport A,. Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology 2009; 14: 455-461.
15. Davies SJ, Phillips L, Naish PF, Russell GI,. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol. Dial. Transplant. 2002; 17: 1085-1092.
16. Chaudhri S, Fan S, Davenport A,. Pitfalls in the measurement of skin autofluorescence to determine tissue advanced glycosylation content in haemodialysis patients. Nephrology 2013; 18: 671-675.
17. Koetsier M, Nur E, Chunmao H, et al. Skin color independent assessment of aging using skin autofluorescence. Opt. Express 2010; 18: 14416-14429.
18. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW,. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin. J. Am. Soc. Nephrol. 2011; 6: 2356-2363.
19. Daffu G, del Pozo CH, O'Shea KM, Ananthakrishnan R, Ramasamy R, Schmidt AM,. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int. J. Mol. Sci. 2013; 14: 19891-19910.
20. Schwedler SB, Metzger T, Schinzel R, Wanner C,. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int. 2002; 62: 301-310.
21. Roberts MA, Thomas MC, Fernando D, Macmillan N, Power DA, Ierino FL,. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. Nephrol. Dial. Transplant. 2006; 21: 1611-1617.
22. Graaff R, Arsov S, Ramsauer B, et al. Skin and plasma autofluorescence during hemodialysis: A pilot study. Artif. Organs 2014; 38: 515-518.
23. Arsov S, Trajceska L, van Oeveren W, et al. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients. Artif. Organs 2013; 37: E114-122.
24. Siriopol D, Hogas S, Veisa G, et al. Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis. Int. Urol. Nephrol. 2015; 47: 563-569.
25. Jadoul M, Ueda Y, Yasuda Y, et al. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of 'carbonyl stress'. Kidney Int. 1999; 55: 2487-2492.
26. Kimura H, Tanaka K, Kanno M, et al. Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis. Ther. Apher. Dial. 2014; 18: 461-467.
27. McIntyre NJ, Chesterton LJ, John SG, et al. Tissue-advanced glycation end product concentration in dialysis patients. Clin. J. Am. Soc. Nephrol. 2010; 5: 51-55.
28. de Vos LC, Noordzij MJ, Mulder DJ, et al. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler. Thromb. Vasc. Biol. 2013; 33: 131-138.
29. Yue X, Hu H, Koetsier M, Graaff R, Han C,. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet. Med. 2011; 28: 818-823.
30. Cole N, Bedford M, Cai A, Jones C, Cairns H, Jayawardene S,. Black ethnicity predicts better survival on dialysis despite greater deprivation and co-morbidity: A UK study. Clin. Nephrol. 2014; 82: 77-82.
31. Udayaraj U, Pruthi R, Casula A, Roderick P,. UK Renal Registry 16th annual report: Chapter 6 demographics and outcomes of patients from different ethnic groups on renal replacement therapy in the UK. Nephron Clin. Pract. 2013; 125: 111-125.
32. Roderick P, Byrne C, Casula A, et al. Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales. Nephrol. Dial. Transplant. 2009; 24: 3774-3782.
33. Nongnuch A, Davenport A,. The effect of vegetarian diet on skin autofluorescence measurements in haemodialysis patients. Br. J. Nutr. 2015; 113: 1040-1043.